The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Immunogenicity of engineered antibodies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Gordon, M. S., Margolin, K., Talpaz, M., Sledge, G. W., Holmgren, E., Benjamin, R., Stalter, S., Shak, S., & Adelman, D. C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.843 · Cited by 913
Natalizumab for Active Crohn's Disease
Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnálek, P., Zádorová, Z., Palmer, T., & Donoghue, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020732 · Cited by 808
(2011) · Hepatogastroenterology · doi:10.5754/hge11387 · Cited by 660
Kaminski, M. S., Zelenetz, A. D., Press, O. W., Saleh, M., Leonard, J., Fehrenbacher, L., Lister, T. A., Stagg, R. J., Tidmarsh, G. F., Kroll, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.19.3918 · Cited by 584
Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 369
Piro, L. D., White, C. A., Grillo-López, A. J., Janakiraman, N., Saven, A., Beck, T. M., Varns, C., Shuey, S., Czuczman, M., Lynch, J. W., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008389119525 · Cited by 368
Margolin, K., Gordon, M. S., Holmgren, E., Gaudreault, J., Novotny, W., Fyfe, G., Adelman, D., Stalter, S., & Breed, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.851 · Cited by 364
Humanised monoclonal antibody therapy for rheumatoid arthritis
Isaacs, J. D., Hale, G., Cobbold, S. P., Waldmann, H., Watts, R. A., Hazleman, B. L., & Keogan, M. T. (1992) · The Lancet · doi:10.1016/0140-6736(92)92294-p · Cited by 308
Immunologic Specificity and Molecular Structure
Karush, F. (1963) · Advances in Immunology · doi:10.1016/s0065-2776(08)60110-8 · Cited by 299
Sandborn, W. J., Feagan, B. G., Hanauer, S. B., Present, D. H., Sutherland, L. R., Kamm, M. A., Wolf, D. C., Baker, J. P., Hawkey, C., Archambault, A., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.24042 · Cited by 257
Handgretinger, R., Anderson, K., Lang, P., Dopfer, R., Klingebiel, T., Schrappe, M., Reuland, P., Gillies, S. D., Reisfeld, R. A., & Niethammer, D. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00413-y · Cited by 213
Tolcher, A. W., Ochoa, L., Hammond, L. A., Patnaik, A., Edwards, T., Takimoto, C., Smith, L., de Bono, J., Schwartz, G., Mays, T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.137 · Cited by 206
Posey, J. A., Khazaeli, M. B., DelGrosso, A., Saleh, M. N., Lin, C. Y., Huse, W., & LoBuglio, A. F. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801300189218 · Cited by 190
Carpenter, P. A., Appelbaum, F. R., Corey, L., Deeg, H. J., Doney, K., Gooley, T., Krueger, J., Martin, P., Pavlovic, S., Sanders, J., et al. (2002) · Blood · doi:10.1182/blood.v99.8.2712 · Cited by 172
Jurcic, J. G., DeBlasio, T., Dumont, L., Yao, T., & Scheinberg, D. A. (2000) · PubMed · Cited by 159
Ritter, G., Cohen, L., Williams, C., Richards, E. C., Old, L. J., & Welt, S. (2001) · PubMed · Cited by 142
Stephens, S., Emtage, S., Vetterlein, O. M., Chaplin, L. C., Bebbington, C. R., Nesbitt, A. M., Sopwith, M., Athwal, D., Novak, C., & Bodmer, M. (1995) · PubMed Central · Cited by 124
Murray, J. L., Cunningham, J. E., Brewer, H., et al. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.184 · Cited by 120
Colnot, D. R., Quak, J. J., Roos, J. C., van Lingen, A., Wilhelm, A. J., van Kamp, G. J., Huijgens, P. C., Snow, G. B., & van Dongen, G. A. M. S. (2000) · PubMed · Cited by 83
Uckun, F. M., Messinger, Y. H., Chen, C., O'Neill, K., Myers, D. E., Goldman, F. D., Hurvitz, C. G., Casper, J. T., & Levine, A. (1999) · PubMed · Cited by 75
Colnot, D. R., Roos, J. C., de Bree, R., Wilhelm, A. J., Kummer, J. A., Hanft, G., Heider, K., Stehle, G., Snow, G. B., & van Dongen, G. A. M. S. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0396-5 · Cited by 72
Czuczman, M. S., Straus, D. J., Divgi, C. R., Graham, M. C., Garin‐Chesa, P., Finn, R., Myers, J., Old, L. J., Larson, S. M., & Scheinberg, D. A. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.2021 · Cited by 68
Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6
Legouffe, É., Liautard, J., GAILLARD, J. P., Rossi, J.-F., Wijdenes, J., Bataille, R., Klein, B., & Brochier, J. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06145.x · Cited by 54
Lamers, C. H. J., Gratama, J. W., Warnaar, S. O., Stoter, G., & Bolhuis, R. L. H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600405 · Cited by 46
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis*
Bowen, J. D., Petersdorf, S. H., Richards, T. L., Maravilla, K. R., Dale, D. C., Price, T. H., John, T. S., & Yu, A. S. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90183-7 · Cited by 36
van Zanten-Przybysz, I., Molthoff, C. F. M., Gebbinck, J. W. T. M. K., von Mensdorff‐Pouilly, S., Verstraeten, R. A., Kenemans, P., & Verheijen, R. H. M. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0348-z · Cited by 35
Crombet, T., Torres, O., Neninger, E., Catalá, M., Rodríguez, N., Ramos, M., Fernández, E., Iznaga, N., Pérez, R., & Lage, A. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801750096122 · Cited by 25
Renner, C., Hartmann, F., Jung, W. E., Deisting, C., Juwana, M., & Pfreundschuh, M. G. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050617 · Cited by 23
Pilot clinical trial of an anti-TNFα monoclonal antibody for the treatment of septic shock
Boillot, A., Capellier, G., Racadot, E., et al. (1995) · Clinical Intensive Care · doi:10.1080/714028874 · Cited by 11
Tibben, J. G., Thomas, C. M. G., Massuger, L. F. A. G., Segers, M. F., Schijf, C. P. T., Corstens, F. H., & Boerman, O. C. (1995) · Nuclear Medicine Communications · doi:10.1097/00006231-199510000-00009 · Cited by 8
Cited by
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Potent antibody therapeutics by design
Carter, P. J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1837 · Cited by 1,099
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence
Chinen, A. B., Guan, C. M., Ferrer, J. R., Barnaby, S. N., Merkel, T. J., & Mirkin, C. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00321 · Cited by 1,032
Development trends for human monoclonal antibody therapeutics
Nelson, A. L., Dhimolea, E., & Reichert, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3229 · Cited by 1,026
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
Wang, W., Wang, E., & Balthasar, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.170 · Cited by 978
Metadata
- Authors
- Hwang, W. Y. K., & Foote, J.
- Venue
- Methods
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 36
- Issue
- 1
- Pages
- 3-10
- ISSN
- 1046-2023 (ISSN-L)
- OpenAlex
- W2028450449
- Cited by
- 630
- References
- 31
- FWCI
- 17.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.